2024/0963 - VACINA CONTRA O VÍRUS DO PAPILOMA HUMANO NONAVALENTE (HPV9) [DOSE]
TED · 324852-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 22 | — | 2026-08-04 |
| GILEAD SCIENCES, LDA | 18 | — | 2026-07-28 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 15 | €1,569,649 | 2026-08-04 |
| NOVARTIS FARMA - PROD.FARM SA | 11 | — | 2026-08-04 |
| JANSSEN-CILAG FARMACEUTICA LDA | 9 | €371,730 | 2026-08-04 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33651500 Medical equipment & pharmaceuticalsDescription
VACINA CONTRA O VÍRUS DO PAPILOMA HUMANO NONAVALENTE (HPV9) [DOSE]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-09 | 2024/0963 -VACINA CONTRA A DOENÇA MENINGOCOCÓCICA B (Men B) [UDOSE] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-07-07 | 2024/0963 - VACINA POLISSACÁRIDA CONJUGADA CONTRA A DOENÇA PNEUMOCÓCICA DE 20 VALÊNCIAS (Pn20) [UDOSE] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-06-24 | 2023/0438 - PLASMA HUMANO (ml) | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-06-30 | 2024/0900 - DOLUTEGRAVIR [50 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-08-04 | 2024/0961 - APALUTAMIDA [240 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-05-12 | 2025/1589 - MARIBAVIR [200 MG COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 91% |